Premium Nahrungsergänzungsmittel | artgerecht

Quercetin Bioavailability Markers Explained

Quercetin bioavailability markers are measurable biological parameters that indicate how effectively quercetin is absorbed and utilized by the human body.

Regular tips about health Regular tips about health

Things worth knowing about "Quercetin bioavailability markers"

Quercetin bioavailability markers are measurable biological parameters that indicate how effectively quercetin is absorbed and utilized by the human body.

What are Quercetin Bioavailability Markers?

Quercetin bioavailability markers are biological measurement parameters that describe the extent to which the flavonoid quercetin – consumed through food or a dietary supplement – actually enters the bloodstream, is distributed into tissues, and becomes biologically active. Bioavailability is a central concept in pharmacology and nutritional science, referring to the fraction of an ingested substance that reaches the systemic circulation unchanged and is thus available at its site of action.

Quercetin is one of the most extensively studied dietary flavonoids and occurs naturally in foods such as onions, apples, broccoli, capers, and grapes. Since quercetin in food is primarily present as a glycoside (bound to a sugar molecule), it must first be enzymatically cleaved in the intestine before absorption can occur. Its bioavailability is therefore highly dependent on individual factors.

Key Quercetin Bioavailability Markers

Various biological markers are used to assess quercetin bioavailability:

Plasma quercetin concentration: The most common measurement parameter. After quercetin intake, the rise of the quercetin level in blood plasma is tracked over time (C_max, t_max, AUC – area under the curve).
Quercetin metabolites in plasma and urine: Quercetin is converted in the intestine and liver into metabolites such as isorhamnetin, tamarixetin, and kaempferol. The presence of these metabolites in blood and urine is a direct indicator of absorption and metabolic processing.
Urinary quercetin excretion: The renal excretion of quercetin and its conjugates (glucuronides, sulfates) serves as an indirect marker of systemic availability.
Relative bioavailability (compared to a reference formulation): A standardized value indicating the percentage of the dose reaching the bloodstream relative to a reference (e.g., intravenous administration).
Gut microbiota-associated markers: Since the intestinal microbiome plays a major role in converting quercetin glycosides, microbial metabolites such as 3,4-dihydroxyphenylacetic acid can serve as indirect bioavailability markers.
Inflammation markers (CRP, IL-6): Indirect functional markers indicating whether absorbed quercetin is biologically active (e.g., anti-inflammatory effect).
Oxidative stress markers (TBARS, F2-isoprostanes): Since quercetin has antioxidant properties, a reduction in oxidative stress markers after intake can be regarded as a functional bioavailability marker.

Factors Influencing Quercetin Bioavailability

The bioavailability of quercetin depends on numerous factors that must be considered when interpreting these markers:

Glycoside form: Quercetin-3-glucoside (e.g., from onions) is absorbed more rapidly than quercetin rutinoside (rutin), since glucosides are cleaved more efficiently by intestinal enzymes.
Formulation: Lipid-based formulations, nanoparticles, or phytosome complexes (e.g., quercetin-phosphatidylcholine) can significantly enhance bioavailability.
Co-ingestion with food: High-fat meals promote absorption, as quercetin has lipophilic properties.
Gut microbiota: Individual differences in the microbial composition of the gut lead to substantial interindividual variation in bioavailability.
Genetic factors: Polymorphisms in enzymes such as catechol-O-methyltransferase (COMT) and intestinal transporters influence quercetin metabolism.
Matrix effects: The food source of quercetin affects its release and absorption (e.g., apples versus dietary supplements).

Clinical Relevance

Understanding quercetin bioavailability markers is clinically significant because only sufficiently absorbed quercetin can exert its proposed health benefits. These include anti-inflammatory, antioxidant, antiviral, and cardioprotective effects. In clinical trials, bioavailability markers are used to compare the efficacy of different quercetin formulations or dosing regimens and to develop optimal supplementation strategies.

For consumers and patients, it is important to know that commercially available quercetin preparations can differ considerably in their bioavailability. High-quality products typically provide evidence from bioavailability studies specific to their formulation.

References

Manach C. et al.: Quercetin, a flavonoid: intake, metabolism and bioavailability. In: Journal of Nutrition, 134(10):2588S-2592S, 2004. PubMed PMID: 15465750.
Boots AW. et al.: Health effects of quercetin: From antioxidant to nutraceutical. In: European Journal of Pharmacology, 585(2-3):325-337, 2008. PubMed PMID: 18417116.
European Food Safety Authority (EFSA): Scientific Opinion on the safety of quercetin as a food supplement. EFSA Journal, 2011;9(7):2279.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.